This year's Antibody Development & Production conference brings together experts from upstream and downstream processing to address how technical, scientific and regulatory changes in the industry are impacting companies of all sizes.
IBC's Biopharmaceutical Development & Production Week will feature FDA and EMEA Feedback from QbD Case Study on Wednesday, March 3, 2010. Results from the CMC Biotech Working Group will be presneted presented by Eli Lilly and Company and Pfizer Inc.
IBC Life Sciences is pleased to announce Biopharmaceutical Development & Production Week, which includes five conferences bringing in perspectives from multiple biopharmaceutical disciplines all under one roof.
IBC's Annual Well Characterized Biologicals conference is dedicated to bringing the freshest content to the industry to help drive forward protein characterization efforts and new technology implementation: FDA perspectives, case studies, unpublished new data...